Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
TFF Pharmaceuticals (DE:0K3)
FRANKFURT:0K3
RESEARCH TOOLSreports
TFF Pharmaceuticals (0K3) Stock Price & Analysis
0 Followers
0K3 Stock Chart & Stats
Day’s Range€8.91 - €8.91
52-Week Range― - ―
Previous Close€8.91
Volume0.00
Average Volume (3M)N/A
Market Cap
$689.89K
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next Earnings
May 09, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€15.52Price Target Upside74.21% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
TFF Pharmaceuticals News
0K3 FAQ
What was TFF Pharmaceuticals’s price range in the past 12 months?
Currently, no data Available
What is TFF Pharmaceuticals’s market cap?
Currently, no data Available
When is TFF Pharmaceuticals’s upcoming earnings report date?
TFF Pharmaceuticals’s upcoming earnings report date is May 09, 2024 which is in 15 days.
How were TFF Pharmaceuticals’s earnings last quarter?
TFF Pharmaceuticals released its earnings results on Nov 14, 2023. The company reported -€2.051 earnings per share for the quarter, beating the consensus estimate of -€2.62 by €0.57.
Is TFF Pharmaceuticals overvalued?
According to Wall Street analysts TFF Pharmaceuticals’s price is currently Undervalued.
Does TFF Pharmaceuticals pay dividends?
TFF Pharmaceuticals does not currently pay dividends.
What is TFF Pharmaceuticals’s EPS estimate?
TFF Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does TFF Pharmaceuticals have?
Currently, no data Available
What happened to TFF Pharmaceuticals’s price movement after its last earnings report?
TFF Pharmaceuticals reported an EPS of -€2.051 in its last earnings report, beating expectations of -€2.62. Following the earnings report the stock price went up 3.518%.
Which hedge fund is a major shareholder of TFF Pharmaceuticals?
Among the largest hedge funds holding TFF Pharmaceuticals’s share is Carlson Capital LP. It holds TFF Pharmaceuticals’s shares valued at 43M.
---
TFF Pharmaceuticals Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€15.52 (74.21% Upside)
€15.52 (74.21% Upside)
Blogger Sentiment
Bullish
DE:0K3 Sentiment 100%
Sector Average 70%
Sector Average 70%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-66.42%
12-Months-Change
Fundamentals
Return on Equity
-150.43%
Trailing 12-Months
Asset Growth
-26.41%
Trailing 12-Months
Company Description
TFF Pharmaceuticals
TFF Pharmaceuticals, Inc. operates as an early-stage biopharmaceutical company. It develops and commercializes drug products based on its Thin film Freezing (TFF) technology platform. The firm also engages in research, development & drug formulation and initial testing of drug products. The company was founded in 2005 and is headquartered in Toronto, Canada.
---
0K3 Earnings Call
Q3 2023
0:00 / 0:00
---
0K3 Stock 12 Months Forecast
Average Price Target
€15.52
▲(74.21% Upside)
Technical Analysis
TFF Pharmaceuticals
―
Durect
―
Aptose Biosciences
―
Galectin Therapeutics
―
Protagonist Therapeutics
―
Best Analysts Covering 0K3
1 Year
1 Year Success Rate
1/8 ratings generated profit
1 Year Average Return
-42.51%
reiterated a buy rating 5 months ago
Copying Jonathan Aschoff's trades and holding each position for 1 Year would result in 12.50% of your transactions generating a profit, with an average return of -42.51% per trade.
---